Medicare and Medicaid Programs: Application From the American Association for Accreditation of Ambulatory Surgery Facilities, Inc. (AAAASF) for Its Outpatient Physical Therapy and Speech Language Pathology Services Accreditation Program, 12260-12262 [2019-06149]
Download as PDF
12260
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
for public written comments on these
determinations on the CMS website by
early September 2019. This website can
be accessed at https://www.cms.gov/
Medicare/Medicare-Fee-for-ServicePayment/ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/. Interested parties
may submit written comments on the
preliminary determinations for new and
reconsidered codes by early October
2019, to the address specified in the
ADDRESSES section of this notice or
electronically to our CLFS dedicated
email box, CLFS_Annual_Public_
Meeting@cms.hhs.gov (the specific date
for the publication of the determinations
on the CMS website, as well as the
deadline for submitting comments
regarding the determinations, will be
published on the CMS website). Final
determinations for new test codes to be
included for payment on the CLFS for
CY 2020 and reconsidered codes will be
posted on the CMS website in
November 2019, along with the
rationale for each determination, the
data on which the determinations are
based, and responses to comments and
suggestions received from the public.
The final determinations with respect to
reconsidered codes are not subject to
further reconsideration. With respect to
the final determinations for new test
codes, the public may request
reconsideration of the basis and amount
of payment as set forth in § 414.509.
III. Registration Instructions
The Division of Ambulatory Services
in the CMS Center for Medicare is
coordinating the CLFS Annual Public
Meeting registration. Beginning April 8,
2019, and ending June 10, 2019,
registration may be completed on-line at
https://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/
ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/. On this web
page, under the heading ‘‘Meeting
Notice, Registration and Agenda,’’ you
will find a link entitled ‘‘Register for
CLFS Annual Meeting’’. Click this link
and enter the required information. All
the following information must be
submitted when registering:
• Name.
• Company name.
• Address.
• Telephone numbers.
• Email addresses.
When registering, individuals who
want to make a presentation must also
specify the new test codes on which
they will be presenting comments. A
confirmation will be sent upon receipt
of the registration. Individuals must
register by the date specified in the
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
DATES section of this notice. Registration
is only required for individuals
attending the meeting in person.
If not attending the CLFS Annual
Public Meeting in person, the public
may view the meeting via webcast or
listen by teleconference. During the
public meeting, webcasting is accessible
online at https://cms.gov/live.
Teleconference dial-in information will
appear on the final CLFS Annual Public
Meeting agenda, which will be posted
on the CMS website when available at
https://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/
ClinicalLabFeeSched/
index.html?redirect=/
ClinicalLabFeeSched/.
IV. Security, Building, and Parking
Guidelines
The meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. We suggest that you
arrive at the CMS campus and parking
facilities between 7:00 a.m. and 8:00
a.m. E.D.T., so that you will be able to
arrive promptly at the meeting by 8:00
a.m. E.D.T. Individuals who are not
registered in advance will not be
permitted to enter the building and will
be unable to attend the meeting. We
note that the public may not enter the
CMS building earlier than 7:15 a.m.
E.D.T. (45 minutes before the convening
of the meeting).
Security measures include the
following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel. Persons without
proper identification may be denied
access to the building.
• Interior and exterior inspection of
vehicles (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Passing through a metal detector
and inspection of items brought into the
building. We note that all items brought
to CMS, whether personal or for the
purpose of demonstration or to support
a demonstration, are subject to
inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
V. Special Accommodations
Individuals attending the meeting
who are hearing or visually impaired
and have special requirements, or a
condition that requires special
assistance, should provide that
information upon registering for the
meeting. The deadline for registration is
listed in the DATES section of this notice.
VI. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–06148 Filed 3–29–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3369–FN]
Medicare and Medicaid Programs:
Application From the American
Association for Accreditation of
Ambulatory Surgery Facilities, Inc.
(AAAASF) for Its Outpatient Physical
Therapy and Speech Language
Pathology Services Accreditation
Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the American
Association for Accreditation of
Ambulatory Surgery Facilities, Inc.
(AAAASF) for continued recognition as
a national accrediting organization for
clinics, rehabilitation agencies, or
public health agencies that furnish
outpatient physical therapy and speech
language pathology services that wish to
participate in the Medicare or Medicaid
programs.
DATES: The approval announced in this
notice is effective on April 4, 2019
through April 4, 2025.
FOR FURTHER INFORMATION CONTACT: Erin
Imhoff, (410) 786–2337; Monda Shaver,
(410) 786–3410; or Tara Lemons, (410)
786–3030.
SUMMARY:
E:\FR\FM\01APN1.SGM
01APN1
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
SUPPLEMENTARY INFORMATION:
I. Background
Under Section 1861(p) of the Social
Security Act (the Act), eligible
beneficiaries may receive outpatient
physical therapy and speech language
pathology (OPT) services from a
provider of services, a clinic,
rehabilitation agency, a public health
agency, or others, provided certain
requirements are met. Section
1832(a)(2)(C) of the Act permits
payment for OPT services. Regulations
concerning provider agreements are at
42 CFR part 489 and those pertaining to
activities relating to the survey and
certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part
485 subpart H, specify the conditions
that a clinic, rehabilitation agency or
public health agency (‘‘OPT providers’’)
must meet in order to participate in the
Medicare program, the scope of covered
services, and the conditions for
Medicare payment for OPT providers.
Generally, to enter into an agreement,
an OPT provider must first be certified
by a State survey agency as complying
with the conditions of participation set
forth in part 485, subpart H of our
Medicare regulations. Thereafter, the
OPT provider is subject to regular
surveys by a state survey agency to
determine whether it continues to meet
these requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)
approved national accrediting
organization (AO) that all applicable
Medicare conditions are met or
exceeded, we may deem those provider
entities as having met the requirements.
Accreditation by an AO is voluntary and
is not required for Medicare
participation.
If an AO is recognized by the
Secretary of the Department of Health
and Human Services (the Secretary) as
having standards for accreditation that
meet or exceed Medicare requirements,
any provider entity accredited by the
national accrediting body’s approved
program may be deemed to meet the
Medicare conditions. An AO applying
for approval of its accreditation program
under part 488, subpart A, must provide
CMS with reasonable assurance that the
AO requires the accredited provider
entities to meet requirements that are at
least as stringent as the Medicare
conditions. Our regulations concerning
the approval of AOs are set forth at
§ 488.5.
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
II. Application Approval Process
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMSapproval of an accreditation program is
conducted in a timely manner. The Act
provides us 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination, to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, we must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
of the 210-day period, we must publish
a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
On October 30, 2018, we published a
proposed notice in the Federal Register
(83 FR 54591) announcing the American
Association for Accreditation of
Ambulatory Surgery Facilities, Inc.
(AAAASF’s) request for continued
approval of its Medicare OPT
accreditation program. In the proposed
notice, we detailed our evaluation
criteria. Under Section 1865(a)(2) of the
Act and in our regulations at § 488.5, we
conducted a review of AAAASF’s
Medicare OPT accreditation renewal
application in accordance with the
criteria specified by our regulations,
which include, but are not limited to the
following:
• An onsite administrative review of
AAAASF’s: (1) Corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its OPT surveyors; (4)
ability to investigate and respond
appropriately to complaints against
accredited OPTs; and, (5) survey review
and decision-making process for
accreditation.
• The comparison of AAAASF’s
Medicare OPT accreditation program
standards to our current Medicare OPT
CoPs.
• A documentation review of
AAAASF’s survey process to:
++ Determine the composition of the
survey team, surveyor qualifications,
and AAAASF’s ability to provide
continuing surveyor training.
++ Compare AAAASF’s processes to
those we require of state survey
agencies, including periodic resurvey
and the ability to investigate and
respond appropriately to complaints
against accredited OPTs.
++ Evaluate AAAASF’s procedures
for monitoring OPTs it has found to be
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
12261
out of compliance with AAAASF’s
program requirements. (This pertains
only to monitoring procedures when
AAAASF identifies non-compliance. If
noncompliance is identified by a state
survey agency through a validation
survey, the state survey agency monitors
corrections as specified at § 488.9(c).)
++ Assess AAAASF’s ability to report
deficiencies to the surveyed OPT and
respond to the OPTs plan of correction
in a timely manner.
++ Establish AAAASF’s ability to
provide CMS with electronic data and
reports necessary for effective validation
and assessment of the organization’s
survey process.
++ Determine the adequacy of
AAAASF’s staff and other resources.
++ Confirm AAAASF’s ability to
provide adequate funding for
performing required surveys.
++ Confirm AAAASF’s policies with
respect to surveys being unannounced.
++ Obtain AAAASF’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
In accordance with section
1865(a)(3)(A) of the Act, the October 30,
2018 proposed notice also solicited
public comments regarding whether
AAAASF’s requirements met or
exceeded the Medicare CoPs for OPTs.
We received no comments in response
to our proposed notice.
IV. Provisions of the Final Notice
A. Differences Between AAAASF’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared AAAASF’s OPT
accreditation program requirements and
survey process with the Medicare CoPs
at part 485 subpart H, and the survey
and certification process requirements
of parts 488 and 489. Our review and
evaluation of AAAASF’s OPT
application, which were conducted as
described in section III of this final
notice, yielded the following areas
where, as of the date of this notice,
AAAASF has revised its standards and
certification processes in order to meet
the requirements at:
• Section 485.701, to ensure
AAAASF’s standards appropriately
reference the CMS standards;
• Section 485.703, definition of
‘‘supervision’’ at (2)(ii), to ensure
AAAASF’s standards appropriately
reference the CMS standards;
• Section 485.705(a), to ensure
AAAASF’s standards appropriately
reference the CMS standards;
E:\FR\FM\01APN1.SGM
01APN1
12262
Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices
• Section 485.705(c)(2) through (c)(6),
to ensure AAAASF’s standards
appropriately reference the CMS
standards;
• Section 485.719(b)(3), to ensure
AAAASF’s standards appropriately
reference the statutory requirements;
• Section 488.5(a)(4)(ii), to ensure
that an appropriate number of medical
records are fully reviewed during the
survey process and that survey record
totals are accurately reflected in the
overall deficiency statement;
• Section 488.5(a)(4)(iv), to ensure all
deficiencies found on survey are cited
in AAAASF’s final survey report;
• Section 488.5(a)(4)(vii), to ensure
appropriate monitoring of noncompliance correction;
• Section 488.5(a)(11)(ii), to ensure
accurate survey findings are reported to
CMS;
• Section 488.5(a)(13)(ii), to ensure
AAAASF notifies CMS regarding any
decision to revoke, withdraw, or revise
the accreditation status of a deemed
status supplier;
• Section 488.26(b) and (c), to ensure
deficiencies are cited at the appropriate
level based on manner and degree of
findings;
• Section 488.28(a), to ensure
AAAASF’s policies for an acceptable
plan of correction meet the CMS
requirements;
• Section 488.28(d), to ensure that
AAAASF’s policies for correction of
deficiencies in OPTs is comparable to
CMS requirements, requiring that
deficiencies normally must be corrected
within 60 days; and
• Section 489.13(b)(1), to ensure all
enrollment requirements are met prior
to AAAASF surveying an initial
applicant.
B. Term of Approval
Based on our review and observations
described in section III of this final
notice, we approve AAAASF as a
national accreditation organization for
OPTs that request participation in the
Medicare program, effective April 4,
2019 through April 4, 2025.
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or third
party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
VerDate Sep<11>2014
17:22 Mar 29, 2019
Jkt 247001
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–06149 Filed 3–29–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–0895]
Issuance of Priority Review Voucher;
Material Threat Medical
Countermeasure Product
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Act, go to https://www.fda.gov/
EmergencyPreparedness/
Counterterrorism/MedicalCounter
measures/MCMLegalRegulatoryand
PolicyFramework/ucm566498.htm#prv.
For further information about TPOXX
(tecovirimat), go to the ‘‘Drugs@FDA’’
website at https://
www.accessdata.fda.gov/scripts/cder/
daf/.
Dated: March 26, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019–06145 Filed 3–29–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice.
The Food and Drug
Administration (FDA) is announcing the
issuance of a priority review voucher to
the sponsor of a material threat medical
countermeasure (MCM) product
application. The Federal Food, Drug,
and Cosmetic Act (FD&C Act), as
amended by the 21st Century Cures Act
(Cures Act), authorizes FDA to award
priority review vouchers to sponsors of
approved material threat MCM product
applications that meet certain criteria.
FDA is required to publish notice of the
award of the priority review voucher.
On July 13, 2018, FDA determined that
TPOXX (tecovirimat), manufactured by
SIGA Technologies, Inc., meets the
criteria for a priority review voucher.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Sadove, Office of
Counterterrorism and Emerging Threats,
10903 New Hampshire Ave., Silver
Spring, MD 20993–0002, 301–796–8510.
SUPPLEMENTARY INFORMATION: FDA is
announcing the issuance of a priority
review voucher to the sponsor of an
approved material threat MCM product
application. Under section 565A of the
FD&C Act (21 U.S.C. 360bbb-4a), which
was added by the Cures Act, FDA will
award priority review vouchers to
sponsors of approved material threat
MCM product applications that meet
certain criteria. FDA has determined
that TPOXX (tecovirimat), manufactured
by SIGA Technologies, Inc., meets the
criteria for a priority review voucher.
TPOXX (tecovirimat) is indicated to
treat human smallpox disease in adults
and pediatric patients weighing at least
13 kilograms.
For further information about the
material threat MCM Priority Review
Voucher Program and for a link to the
full text of section 565A of the FD&C
Food and Drug Administration
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
[Docket No. FDA–2019–N–0598]
Teva Women’s Health, Inc., et al.;
Withdrawal of Approval of 16 New
Drug Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
withdrawing approval of 16 new drug
applications (NDAs) from multiple
applicants. The applicants notified the
Agency in writing that the drug
products were no longer marketed and
requested that the approval of the
applications be withdrawn.
SUMMARY:
Approval is withdrawn as of
May 1, 2019.
DATES:
FOR FURTHER INFORMATION CONTACT:
Kimberly Lehrfeld, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6226,
Silver Spring, MD 20993–0002, 301–
796–3137.
The
applicants listed in the table have
informed FDA that these drug products
are no longer marketed and have
requested that FDA withdraw approval
of the applications under the process in
§ 314.150(c) (21 CFR 314.150(c)). The
applicants have also, by their requests,
waived their opportunity for a hearing.
Withdrawal of approval of an
application or abbreviated application
under § 314.150(c) is without prejudice
to refiling.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\01APN1.SGM
01APN1
Agencies
[Federal Register Volume 84, Number 62 (Monday, April 1, 2019)]
[Notices]
[Pages 12260-12262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3369-FN]
Medicare and Medicaid Programs: Application From the American
Association for Accreditation of Ambulatory Surgery Facilities, Inc.
(AAAASF) for Its Outpatient Physical Therapy and Speech Language
Pathology Services Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve the
American Association for Accreditation of Ambulatory Surgery
Facilities, Inc. (AAAASF) for continued recognition as a national
accrediting organization for clinics, rehabilitation agencies, or
public health agencies that furnish outpatient physical therapy and
speech language pathology services that wish to participate in the
Medicare or Medicaid programs.
DATES: The approval announced in this notice is effective on April 4,
2019 through April 4, 2025.
FOR FURTHER INFORMATION CONTACT: Erin Imhoff, (410) 786-2337; Monda
Shaver, (410) 786-3410; or Tara Lemons, (410) 786-3030.
[[Page 12261]]
SUPPLEMENTARY INFORMATION:
I. Background
Under Section 1861(p) of the Social Security Act (the Act),
eligible beneficiaries may receive outpatient physical therapy and
speech language pathology (OPT) services from a provider of services, a
clinic, rehabilitation agency, a public health agency, or others,
provided certain requirements are met. Section 1832(a)(2)(C) of the Act
permits payment for OPT services. Regulations concerning provider
agreements are at 42 CFR part 489 and those pertaining to activities
relating to the survey and certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part 485 subpart H, specify the
conditions that a clinic, rehabilitation agency or public health agency
(``OPT providers'') must meet in order to participate in the Medicare
program, the scope of covered services, and the conditions for Medicare
payment for OPT providers.
Generally, to enter into an agreement, an OPT provider must first
be certified by a State survey agency as complying with the conditions
of participation set forth in part 485, subpart H of our Medicare
regulations. Thereafter, the OPT provider is subject to regular surveys
by a state survey agency to determine whether it continues to meet
these requirements.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by a Centers for Medicare & Medicaid
Services (CMS) approved national accrediting organization (AO) that all
applicable Medicare conditions are met or exceeded, we may deem those
provider entities as having met the requirements. Accreditation by an
AO is voluntary and is not required for Medicare participation.
If an AO is recognized by the Secretary of the Department of Health
and Human Services (the Secretary) as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
may be deemed to meet the Medicare conditions. An AO applying for
approval of its accreditation program under part 488, subpart A, must
provide CMS with reasonable assurance that the AO requires the
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of AOs are set forth at Sec. 488.5.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS-approval of an
accreditation program is conducted in a timely manner. The Act provides
us 210 days after the date of receipt of a complete application, with
any documentation necessary to make the determination, to complete our
survey activities and application process. Within 60 days after
receiving a complete application, we must publish a notice in the
Federal Register that identifies the national accrediting body making
the request, describes the request, and provides no less than a 30-day
public comment period. At the end of the 210-day period, we must
publish a notice in the Federal Register approving or denying the
application.
III. Provisions of the Proposed Notice
On October 30, 2018, we published a proposed notice in the Federal
Register (83 FR 54591) announcing the American Association for
Accreditation of Ambulatory Surgery Facilities, Inc. (AAAASF's) request
for continued approval of its Medicare OPT accreditation program. In
the proposed notice, we detailed our evaluation criteria. Under Section
1865(a)(2) of the Act and in our regulations at Sec. 488.5, we
conducted a review of AAAASF's Medicare OPT accreditation renewal
application in accordance with the criteria specified by our
regulations, which include, but are not limited to the following:
An onsite administrative review of AAAASF's: (1) Corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its OPT surveyors; (4) ability to investigate and respond
appropriately to complaints against accredited OPTs; and, (5) survey
review and decision-making process for accreditation.
The comparison of AAAASF's Medicare OPT accreditation
program standards to our current Medicare OPT CoPs.
A documentation review of AAAASF's survey process to:
++ Determine the composition of the survey team, surveyor
qualifications, and AAAASF's ability to provide continuing surveyor
training.
++ Compare AAAASF's processes to those we require of state survey
agencies, including periodic resurvey and the ability to investigate
and respond appropriately to complaints against accredited OPTs.
++ Evaluate AAAASF's procedures for monitoring OPTs it has found to
be out of compliance with AAAASF's program requirements. (This pertains
only to monitoring procedures when AAAASF identifies non-compliance. If
noncompliance is identified by a state survey agency through a
validation survey, the state survey agency monitors corrections as
specified at Sec. 488.9(c).)
++ Assess AAAASF's ability to report deficiencies to the surveyed
OPT and respond to the OPTs plan of correction in a timely manner.
++ Establish AAAASF's ability to provide CMS with electronic data
and reports necessary for effective validation and assessment of the
organization's survey process.
++ Determine the adequacy of AAAASF's staff and other resources.
++ Confirm AAAASF's ability to provide adequate funding for
performing required surveys.
++ Confirm AAAASF's policies with respect to surveys being
unannounced.
++ Obtain AAAASF's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
In accordance with section 1865(a)(3)(A) of the Act, the October
30, 2018 proposed notice also solicited public comments regarding
whether AAAASF's requirements met or exceeded the Medicare CoPs for
OPTs. We received no comments in response to our proposed notice.
IV. Provisions of the Final Notice
A. Differences Between AAAASF's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared AAAASF's OPT accreditation program requirements and
survey process with the Medicare CoPs at part 485 subpart H, and the
survey and certification process requirements of parts 488 and 489. Our
review and evaluation of AAAASF's OPT application, which were conducted
as described in section III of this final notice, yielded the following
areas where, as of the date of this notice, AAAASF has revised its
standards and certification processes in order to meet the requirements
at:
Section 485.701, to ensure AAAASF's standards
appropriately reference the CMS standards;
Section 485.703, definition of ``supervision'' at (2)(ii),
to ensure AAAASF's standards appropriately reference the CMS standards;
Section 485.705(a), to ensure AAAASF's standards
appropriately reference the CMS standards;
[[Page 12262]]
Section 485.705(c)(2) through (c)(6), to ensure AAAASF's
standards appropriately reference the CMS standards;
Section 485.719(b)(3), to ensure AAAASF's standards
appropriately reference the statutory requirements;
Section 488.5(a)(4)(ii), to ensure that an appropriate
number of medical records are fully reviewed during the survey process
and that survey record totals are accurately reflected in the overall
deficiency statement;
Section 488.5(a)(4)(iv), to ensure all deficiencies found
on survey are cited in AAAASF's final survey report;
Section 488.5(a)(4)(vii), to ensure appropriate monitoring
of non-compliance correction;
Section 488.5(a)(11)(ii), to ensure accurate survey
findings are reported to CMS;
Section 488.5(a)(13)(ii), to ensure AAAASF notifies CMS
regarding any decision to revoke, withdraw, or revise the accreditation
status of a deemed status supplier;
Section 488.26(b) and (c), to ensure deficiencies are
cited at the appropriate level based on manner and degree of findings;
Section 488.28(a), to ensure AAAASF's policies for an
acceptable plan of correction meet the CMS requirements;
Section 488.28(d), to ensure that AAAASF's policies for
correction of deficiencies in OPTs is comparable to CMS requirements,
requiring that deficiencies normally must be corrected within 60 days;
and
Section 489.13(b)(1), to ensure all enrollment
requirements are met prior to AAAASF surveying an initial applicant.
B. Term of Approval
Based on our review and observations described in section III of
this final notice, we approve AAAASF as a national accreditation
organization for OPTs that request participation in the Medicare
program, effective April 4, 2019 through April 4, 2025.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
Dated: March 15, 2019.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2019-06149 Filed 3-29-19; 8:45 am]
BILLING CODE 4120-01-P